Freemium

EU CLOs: Investment Performance Of Asia-Funded Deals EU CLO 2018Alpha (Total annualised)Alpha (MV)Alpha (Interest)Latest WARFAAA from AsiaTier 10.8%0.4%0.4%3,2783Tier 20.4%0.2%0.1%3,1595Tier 30.2%0.0%0.2%3,1962Tier...

EU CLO Manager Rankings: Investment Performance with Attribution (Lower Interest Return Strategy) and Top 5 Managers (Not In Order) The...

"With that one image, at Christmas in 1968, television enabled humankind to understand something that no one before had been...

“There is no better teacher than history in determining the future… There are answers worth billions of dollars in a...

Is An Elevated Level Of Trading Volume A Ticket To Better Investment Performance? This sample size is comprised of 66...

"If I don't know what I don't know, I might think that I know. If I don't know what I...

US CLOs: Relationship Between Investment Performance and Par Build (2018 Cohort) And Whose Deals Are In The Top Tier Groups?...

EU CLOs: Solid Track Record (Arbitrage) The European leveraged loan market has staged an extraordinary comeback. As of 30 Nov...

US CLOs: Track Record (In Line With Index But Not Enough) New issue US CLOs are seeing tight liability prints...

Time is an herb that cures all diseases. – Benjamin Franklin 25 Nov: OC Breach Table (Fewer Managers Breached ID/OC...

“He that speaks ill of the Mare will buy it later.”― Benjamin Franklin Trend – CLO Tranche MVOC And Spreads CLO...

"Give and take, that is the essence of what balance is all about. When humankind as a whole is in...

I attribute my success to this: I never gave or took any excuse. –Florence Nightingale US CLOs: 2017 Vintage –...

EU CLOs: 2018 Vintage Analysis – Performance, Par Build, WARF, Asia Funding, Risk Retention EU CLO 2018Alpha (Total annualised)Net Collateral...

Time is an herb that cures all diseases. – Benjamin Franklin 26 Oct: OC Breach Table (More Deals With Less...